down arrow

Norris Medicines

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE744C01029
  • NSEID:
  • BSEID: 524414
INR
16.30
0.3 (1.88%)
BSENSE

Apr 11, 12:34 PM

BSE+NSE Vol: 858

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

15.0017.60

52 Week

10.7027.74
Valuation
Technical
Day's Volume

CASH

858 (272.07%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.07%

Held by 0 DIIs

Promoter

34.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -14.58% and Operating profit at 0% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

Flat results in Dec 24

3

Risky - Negative Operating Profits

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 16 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.50

stock-summary
Return on Equity

5.85%

stock-summary
Price to Book

-1.12

Revenue and Profits (1 Year):
Net Sales:
1 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-10.64%
0%
-10.64%
1 Year
14.31%
0%
14.31%
2 Years
48.18%
0%
48.18%
3 Years
0%
0%
0.0%
4 Years
132.86%
0%
132.86%
5 Years
503.7%
0%
503.7%

Norris Medicines for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-14.58%
EBIT Growth (5y)
10.25%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
-10.69%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
-1.12
EV to EBIT
-37.56
EV to EBITDA
37.56
EV to Capital Employed
5.21
EV to Sales
8.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.69%
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.01%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Vimal D Shah (23.6%)

Highest Public shareholder

Fab Metals Private Limited (41.99%)

Individual Investors Holdings

20.73%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -12.60% vs 76.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 22.22% vs 2.70% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.11",
          "val2": "1.27",
          "chgp": "-12.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.03",
          "val2": "-0.15",
          "chgp": "80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.12",
          "val2": "0.08",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.28",
          "val2": "-0.36",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.70%",
          "val2": "-11.81%",
          "chgp": "9.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -43.14% vs -12.06% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 33.03% vs -9.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.99",
          "val2": "3.50",
          "chgp": "-43.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.31",
          "val2": "-0.63",
          "chgp": "50.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.17",
          "val2": "0.17",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.73",
          "val2": "-1.09",
          "chgp": "33.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.58%",
          "val2": "-18.00%",
          "chgp": "2.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -25.30% vs -41.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 25.74% vs -13.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "4.15",
          "chgp": "-25.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.34",
          "val2": "-0.67",
          "chgp": "49.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "0.26",
          "chgp": "11.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.01",
          "val2": "-1.36",
          "chgp": "25.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.97%",
          "val2": "-16.14%",
          "chgp": "5.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -32.54% vs -11.44% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 32.00% vs 46.32% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.64",
          "val2": "8.36",
          "chgp": "-32.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.18",
          "val2": "0.92",
          "chgp": "-119.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.37",
          "val2": "1.50",
          "chgp": "-75.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.19",
          "val2": "-1.75",
          "chgp": "32.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.19%",
          "val2": "11.00%",
          "chgp": "-14.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1.11
1.27
-12.60%
Operating Profit (PBDIT) excl Other Income
-0.03
-0.15
80.00%
Interest
0.12
0.08
50.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.28
-0.36
22.22%
Operating Profit Margin (Excl OI)
-2.70%
-11.81%
9.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -12.60% vs 76.39% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 22.22% vs 2.70% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1.99
3.50
-43.14%
Operating Profit (PBDIT) excl Other Income
-0.31
-0.63
50.79%
Interest
0.17
0.17
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.73
-1.09
33.03%
Operating Profit Margin (Excl OI)
-15.58%
-18.00%
2.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -43.14% vs -12.06% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 33.03% vs -9.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3.10
4.15
-25.30%
Operating Profit (PBDIT) excl Other Income
-0.34
-0.67
49.25%
Interest
0.29
0.26
11.54%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.01
-1.36
25.74%
Operating Profit Margin (Excl OI)
-10.97%
-16.14%
5.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -25.30% vs -41.88% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 25.74% vs -13.33% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
5.64
8.36
-32.54%
Operating Profit (PBDIT) excl Other Income
-0.18
0.92
-119.57%
Interest
0.37
1.50
-75.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.19
-1.75
32.00%
Operating Profit Margin (Excl OI)
-3.19%
11.00%
-14.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -32.54% vs -11.44% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 32.00% vs 46.32% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Norris Medicines Ltd stock-summary
stock-summary
Norris Medicines Ltd
Micro Cap
Pharmaceuticals & Drugs
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91.
Company Coordinates stock-summary
Company Details
Plot No 801/P & 802, GIDC Industrial Estate Ankleshwar Gujarat : 393002
stock-summary
Tel: 91-2646-223462/227530
stock-summary
http://www.norrispharma.com
stock-summary
secretarial@norrispharma.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."